Dr. Pyke's Supplements   Report issue

For profit Phase 4
Founded: New Fairfield CT United States (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2019
NCT03681392
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

drpykessupplements.com | Pykonsult LLC

Active Ingredients

Drugs in Phase 4 Trials (1)

famotidine (pepcid) (1 trial)

Drugs in Other Trials (4)

citrulline (1 trial)

ginseng (1 trial)

sitosterol, beta- (1 trial)

vitamin d3 (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5